Liquidia (LQDA) EBT Growth (1y) (2021 - 2026)
Liquidia (LQDA) EBT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -324.14% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -1.93% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | -8.74% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 70.52% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 1.69% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 124.00% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Liquidia | 6.38 Bn | 6.09 Bn | 160.92 Mn | 296.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 296.49% |
| Mar 31, 2026 | 248.00% |
| Dec 31, 2025 | 137.80% |
| Sep 30, 2025 | -99.32% |
| Jun 30, 2025 | -11.86% |
| Mar 31, 2025 | 68.54% |
| Dec 31, 2024 | -40.29% |
| Sep 30, 2024 | -141.19% |
| Jun 30, 2024 | -75.98% |
| Mar 31, 2024 | -293.38% |
| Dec 31, 2023 | -435.09% |
| Sep 30, 2023 | -60.94% |
| Jun 30, 2023 | -269.50% |
| Mar 31, 2023 | -95.92% |
| Dec 31, 2022 | 55.29% |
| Sep 30, 2022 | -41.01% |
| Jun 30, 2022 | -80.23% |
| Mar 31, 2022 | 2.59% |
| Dec 31, 2021 | 28.51% |
| Sep 30, 2021 | 8.21% |